FERNANDA CRISTINA LEITE MAGLIARO ABURAYA
Projetos de Pesquisa
Unidades Organizacionais
LIM/34 - Laboratório de Ciências da Reabilitação, Hospital das Clínicas, Faculdade de Medicina
5 resultados
Resultados de Busca
Agora exibindo 1 - 5 de 5
bookPart Potencial evocado auditivo de tronco encefálico(2015) MATAS, Carla Gentile; MAGLIARO, Fernanda Cristina Leite- Auditory Event Related Potentials in children with autism spectrum disorder(2021) KAMITA, Mariana K.; SILVA, Liliane A. F.; MAGLIARO, Fernanda C. L.; FERNANDES, Fernanda D.; MATAS, Carla G.Objective: To analyze auditory cortical processing in high functioning ASD individuals. Methods: Thirty individuals were included in the study (15 with Autism Spectrum Disorder and 15 with typical development), and their Auditory Event Related Potentials evaluation, elicited with tone burst and speech stimuli, were analyzed. Results: There were no significant differences between individuals with high-functioning Autism Spectrum Disorder without intellectual disability and those with typical development in the auditory Event-related Potentials elicited with tone bursts or speech stimuli. Conclusions: The results of Auditory Event Related Potentials did not show any change at the cortical level in individuals with Autism Spectrum Disorder.
- Influence of obstructive sleep apnea on auditory event-related potentials(2022) PEDRENO, Raquel Meirelles; MATSUMURA, Erika; SILVA, Liliane Aparecida Fagundes; SAMELLI, Alessandra Giannella; MAGLIARO, Fernanda Cristina Leite; SANCHES, Seisse Gabriela Gandolfi; LOBO, Ivone Ferreira Neves; LORENZI-FILHO, Geraldo; CARVALLO, Renata Mota Mamede; MATAS, Carla GentilePurpose To evaluate the influence of obstructive sleep apnea (OSA) on the P300 response of auditory event-related potentials (ERPs) and to correlate the electrophysiological findings with OSA severity. Methods Patients with no OSA and mild, moderate, and severe OSA according to polysomnography (PSG) with normal hearing and no comorbidities were studied. Individuals with a body mass index (BMI) >= 40 kg/m(2), hypertension, diabetes, dyslipidemia, the use of chronic medications, and a risk of hearing loss were excluded. All patients underwent full PSG and auditory ERP measurement using the oddball paradigm with tone burst and speech stimuli. For P300 analysis (latencies and amplitudes), normal multiple linear regression models were adjusted with the groups (No OSA, Mild OSA, Moderate OSA, Severe OSA), age, BMI, and Epworth score as explanatory variables. Results We studied 54 individuals (47 males) aged 35 +/- 8 years with a BMI of 28.4 +/- 4.3 kg/m(2). Patients were divided according to the apnea-hypopnea index (AHI) derived from PSG into no OSA (n = 14), mild (n = 16), moderate (n = 12), and severe OSA (n = 12) groups. Patients with severe OSA presented prolonged P300 latencies with tone burst stimuli compared to patients with no OSA and those with mild and moderate OSA. Conclusion Severe OSA is associated with impairment of the P300 response of auditory ERPs, suggesting a decrease in the processing speed of acoustic information that may be mediated by the level of somnolence.
- Severe obstructive sleep apnea is associated with cochlear function impairment(2018) MATSUMURA, Erika; MATAS, Carla G.; SANCHES, Seisse G. G.; MAGLIARO, Fernanda C. L.; PEDRENO, Raquel M.; GENTA, Pedro R.; LORENZI-FILHO, Geraldo; CARVALLO, Renata M. M.The purpose of this study is to investigate the association between obstructive sleep apnea (OSA) with middle ear acoustic transference and cochlear function. Male individuals with and without mild, moderate, and severe OSA according to standard criteria of full polysomnography and no co-morbidities were studied. Subjects with BMI 40 kg/m(2), present or past treatment for OSA, with heart failure, diabetes, hypertension, dyslipidemia, stroke, use of chronic medications, and previous history of risk for hearing loss were excluded. All subjects were submitted to full polysomnography, evaluation of wideband acoustic immittance by energy of absorbance (EA), and distortion product otoacoustic emissions (DPOAE). We studied 38 subjects (age 35.8 +/- 7.2 years, BMI 28.8 +/- 3.8 kg/m(2)) divided into no OSA (n = 10, age 33.6 +/- 6.4 years, BMI 26.9 +/- 4.1 kg/m(2)), mild (n = 11, age 32.8 +/- 2.9 years, BMI 28.5 +/- 3.5 kg/m(2)), moderate (n = 8, age 34.1 +/- 6.8 years, BMI 29.6 +/- 3.3 kg/m(2)), and severe OSA (n = 9, age 41.2 +/- 9.2 years, BMI 30.5 +/- 3.8 kg/m(2)). EA was similar between groups. In contrast, patients with severe OSA presented significantly lower DPOAE amplitudes when compared to the control, mild, and moderate OSA groups (p ae 0.03, for all comparisons). Acoustic transference function of middle ear is similar in adults with and without OSA. Severe OSA is independently associated with cochlear function impairment in patients with no significant co-morbidities.
article 3 Citação(ões) na Scopus Brainstem Auditory Evoked Potential in HIV-Positive Adults(2015) MATAS, Carla Gentile; SAMELLI, Alessandra Giannella; ANGRISANI, Rosanna Giaffredo; MAGLIARO, Fernanda Cristina Leite; SEGURADO, Aluisio C.Background: To characterize the findings of brainstem auditory evoked potential in HIV-positive individuals exposed and not exposed to antiretroviral treatment. Material/Methods: This research was a cross-sectional, observational, and descriptive study. Forty-five HIV-positive individuals (18 not exposed and 27 exposed to the antiretroviral treatment - research groups I and II, respectively - and 30 control group individuals) were assessed through brainstem auditory evoked potential. Results: There were no significant between-group differences regarding wave latencies. A higher percentage of altered brainstem auditory evoked potential was observed in the HIV-positive groups when compared to the control group. The most common alteration was in the low brainstem. Conclusions: HIV-positive individuals have a higher percentage of altered brainstem auditory evoked potential that suggests central auditory pathway impairment when compared to HIV-negative individuals. There was no significant difference between individuals exposed and not exposed to antiretroviral treatment.